165 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 4 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
ABCA6ATP binding cassette subfamily A member 6
Liver Hepatocellular Carcinoma (validation): 2.04e-6
Stomach Adenocarcinoma (TCGA): 2.29e-4
ABCA8ATP binding cassette subfamily A member 8
Liver Hepatocellular Carcinoma (validation): 1.18e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 9.87e-5
Lung Adenocarcinoma (TCGA): 3.24e-4
ABCA9ATP binding cassette subfamily A member 9
Liver Hepatocellular Carcinoma (validation): 2.36e-5
Breast Invasive Carcinoma (validation): 5.14e-4
Liver Hepatocellular Carcinoma (TCGA): 6.62e-4
ACACBAcetyl-CoA carboxylase beta
Kidney Renal Clear Cell Carcinoma (validation): 1.24e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.62e-5
Pancreatic Adenocarcinoma (TCGA): 9.75e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.10e-4
Thyroid Carcinoma (TCGA): 1.44e-4
ACSL1Acyl-CoA synthetase long chain family member 1
Kidney Renal Clear Cell Carcinoma (TCGA): 6.19e-7
Lung Adenocarcinoma (validation): 7.01e-4
ADAM33ADAM metallopeptidase domain 33
Glioblastoma Multiforme (validation): 5.22e-5
ADD3Adducin 3
Kidney Renal Clear Cell Carcinoma (TCGA): 2.77e-9
Ovary Serous Cystadenocarcinoma (validation): 5.69e-5
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptide
Breast Invasive Carcinoma (validation): 9.38e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.37e-4
Liver Hepatocellular Carcinoma (TCGA): 4.23e-4
Liver Hepatocellular Carcinoma (validation): 5.24e-4
Lung Adenocarcinoma (TCGA): 5.64e-4
ADIPOQAdiponectin, C1Q and collagen domain containing
ADMAdrenomedullin
Lung Adenocarcinoma (TCGA): 1.40e-5
Liver Hepatocellular Carcinoma (TCGA): 1.84e-4
Liver Hepatocellular Carcinoma (validation): 3.60e-4
Lung Adenocarcinoma (validation): 4.08e-4
AGTR1Angiotensin II receptor type 1
Kidney Renal Clear Cell Carcinoma (TCGA): 7.11e-7
Kidney Renal Clear Cell Carcinoma (validation): 3.45e-4
ANGPTL1Angiopoietin like 1
Liver Hepatocellular Carcinoma (validation): 1.58e-6
ANPEPAlanyl aminopeptidase, membrane
Kidney Renal Clear Cell Carcinoma (TCGA): 2.36e-7
Lung Adenocarcinoma (validation): 4.98e-4
AOC3Amine oxidase copper containing 3
Lung Squamous Cell Carcinoma (validation): 2.55e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.58e-4
Pancreatic Adenocarcinoma (validation): 2.99e-4
Lung Squamous Cell Carcinoma (TCGA): 9.61e-4
AOX1Aldehyde oxidase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 3.79e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.16e-4
APODApolipoprotein D
AQP7Aquaporin 7
Pancreatic Adenocarcinoma (TCGA): 7.06e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.07e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.33e-4
Lung Adenocarcinoma (validation): 9.56e-4
ASAP3ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.01e-4
Glioblastoma Multiforme (validation): 6.38e-4
BOCBOC cell adhesion associated, oncogene regulated
Kidney Renal Clear Cell Carcinoma (TCGA): 3.91e-6
Ovary Serous Cystadenocarcinoma (TCGA): 6.42e-4
C14orf180Chromosome 14 open reading frame 180
Kidney Renal Clear Cell Carcinoma (TCGA): 4.29e-5
Breast Invasive Carcinoma (validation): 4.01e-4
C1GALT1C1C1GALT1 specific chaperone 1
Kidney Renal Clear Cell Carcinoma (TCGA): 6.11e-8
Breast Invasive Carcinoma (TCGA): 2.47e-4
Glioblastoma Multiforme (validation): 3.38e-4
C1QTNF1C1q and TNF related 1
Colon Adenocarcinoma (validation): 1.21e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.65e-5
C1QTNF7C1q and TNF related 7
Kidney Renal Clear Cell Carcinoma (TCGA): 2.38e-4
C1RComplement C1r
Kidney Renal Clear Cell Carcinoma (TCGA): 2.23e-7
Liver Hepatocellular Carcinoma (validation): 4.77e-5
Pancreatic Adenocarcinoma (validation): 9.50e-4
C1SComplement C1s
Liver Hepatocellular Carcinoma (validation): 1.78e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.07e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.79e-4
Liver Hepatocellular Carcinoma (TCGA): 4.98e-4
C2CD2C2 calcium dependent domain containing 2
Breast Invasive Carcinoma (TCGA): 2.10e-4
Thyroid Carcinoma (TCGA): 7.05e-4
C6Complement C6
Liver Hepatocellular Carcinoma (validation): 4.58e-6
Stomach Adenocarcinoma (TCGA): 8.11e-4
C7Complement C7
Liver Hepatocellular Carcinoma (validation): 1.96e-6
Lung Adenocarcinoma (TCGA): 1.47e-4
Rectum Adenocarcinoma (TCGA): 4.64e-4
Liver Hepatocellular Carcinoma (TCGA): 8.91e-4
CD302CD302 molecule
Kidney Renal Clear Cell Carcinoma (TCGA): 3.59e-5
Lung Adenocarcinoma (TCGA): 1.81e-4
Glioblastoma Multiforme (validation): 3.63e-4
CD81CD81 molecule
Kidney Renal Clear Cell Carcinoma (TCGA): 5.00e-5
Glioblastoma Multiforme (TCGA): 3.35e-4
CDO1Cysteine dioxygenase type 1
Liver Hepatocellular Carcinoma (TCGA): 3.84e-5
Liver Hepatocellular Carcinoma (validation): 4.03e-5
Stomach Adenocarcinoma (TCGA): 4.54e-4
CH25HCholesterol 25-hydroxylase
Liver Hepatocellular Carcinoma (validation): 8.22e-5
Lung Squamous Cell Carcinoma (TCGA): 5.17e-4
CHRDL1Chordin like 1
Lung Adenocarcinoma (TCGA): 3.61e-4
Lung Squamous Cell Carcinoma (TCGA): 9.88e-4
CIDECCell death inducing DFFA like effector c
Kidney Renal Clear Cell Carcinoma (TCGA): 9.14e-5
COL6A3Collagen type VI alpha 3 chain
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.18e-7
COPS8COP9 signalosome subunit 8
Kidney Renal Clear Cell Carcinoma (TCGA): 1.06e-8
Liver Hepatocellular Carcinoma (TCGA): 6.37e-5
Liver Hepatocellular Carcinoma (validation): 8.21e-5
CRTAPCartilage associated protein
Pancreatic Adenocarcinoma (validation): 3.46e-5
Liver Hepatocellular Carcinoma (validation): 1.13e-4
Glioblastoma Multiforme (validation): 5.02e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 6.38e-4
CTSKCathepsin K
Ovary Serous Cystadenocarcinoma (validation): 3.82e-4
Glioblastoma Multiforme (TCGA): 6.99e-4
CXCL12C-X-C motif chemokine ligand 12
Liver Hepatocellular Carcinoma (validation): 6.92e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.53e-4
Ovary Serous Cystadenocarcinoma (TCGA): 9.03e-4
CYB5ACytochrome b5 type A
Kidney Renal Clear Cell Carcinoma (TCGA): 5.38e-8
Liver Hepatocellular Carcinoma (TCGA): 2.16e-4
Glioblastoma Multiforme (validation): 2.34e-4
Colon Adenocarcinoma (TCGA): 2.43e-4
Pancreatic Adenocarcinoma (validation): 9.75e-4
CYBRD1Cytochrome b reductase 1
Glioblastoma Multiforme (validation): 1.98e-4
Ovary Serous Cystadenocarcinoma (TCGA): 9.28e-4
DCUN1D3Defective in cullin neddylation 1 domain containing 3
DDR2Discoidin domain receptor tyrosine kinase 2
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.96e-7
Ovary Serous Cystadenocarcinoma (validation): 2.83e-6
DNAJC28DnaJ heat shock protein family (Hsp40) member C28
DPTDermatopontin
Liver Hepatocellular Carcinoma (validation): 3.29e-4
Ovary Serous Cystadenocarcinoma (TCGA): 5.35e-4
DPYSL2Dihydropyrimidinase like 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.54e-5
Colon Adenocarcinoma (validation): 2.70e-4
ENSG00000248751Novel protein
ENSG00000257411Novel protein
ENSG00000260371Novel protein
Page of 4 | next »